The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Guillain-Barre syndrome associated with Zika virus infection
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The ICR suckling mice model is susceptible to ZIKV infection by both intraperitoneal and intracerebral injection and provides infection with high viral loads in the brain, consistent with severe neurological symptoms in humans.
“The ICR suckling mice model is susceptible for ZIKV infection by using both i.p. and i.c. injection methods and provide infection with high viral loads in the brain, which is consistent with severe neurological symptom in human [12, 14, 25].”
From ICR suckling mouse model of Zika virus infection for disease modeling and drug validation (2018) · cites this paper as [14]
ZIKV infection is associated with severe neurological syndromes, including Guillain-Barré syndrome in adults and microcephaly in infants.
“Cumulative evidence suggests an association between ZIKV infection and microcephaly in newborn infants.”
From ICR suckling mouse model of Zika virus infection for disease modeling and drug validation (2018) · cites this paper as [14]
Citations
Cites
Lanciotti, R. S., Kosoy, O. L., Laven, J. J., Velez, J. O., Lambert, A. J., Johnson, A. J., Stanfield, S. M., & Duffy, M. R. (2008) · Emerging infectious diseases · doi:10.3201/eid1408.080287 · Cited by 2,173
Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastère, S., Valour, F., Baudouin, L., Mallet, H., Musso, D., & Ghawche, F. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.9.20720 · Cited by 1,046
Sejvar, J. J., Kohl, K. S., Gidudu, J., Amato, A. A., Bakshi, N., Baxter, R. P., Burwen, D. R., Cornblath, D. R., Cleerbout, J., Edwards, K. M., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.003 · Cited by 651
Neurological manifestations of dengue infection
Solomon, T., Dung, N. M., Vaughn, D. W., Kneen, R., Thao, L. T. T., Raengsakulrach, B., Loan, H. T., Day, N., Farrar, J., Myint, K. S. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02036-5 · Cited by 635
Self-citationZika virus: following the path of dengue and chikungunya?
Musso, D., Cao‐Lormeau, V., & Gubler, D. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61273-9 · Cited by 403
Zika virus: following the path of dengue and chikungunya?
Isl, M., States, F. M., Isl, S., Isl, F., Isl, N., & Isl, T. C. (2015) · Cited by 328
Flagged first, then by citations
Cited by
Sorted by citations
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
Zhao, H., Shen, D., Zhou, H., Liu, J., & Chen, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30109-5 · Cited by 1,010
Krauer, F., Riesen, M., Revéiz, L., Oladapo, O. T., Martínez-Vega, R. A., Porgo, T. V., Haefliger, A., Broutet, N. J. N., Low, N. N., & WHO Zika Causality Working Group (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002203 · Cited by 517
Vaccine protection against Zika virus from Brazil
Larocca, R. A., Abbink, P., Peron, J. P. S., Zanotto, P. M. D. A., Iampietro, M. J., Badamchi-Zadeh, A., Boyd, M. B., Ng’ang’a, D., Kirilova, M., Nityanandam, R., et al. (2016) · Nature · doi:10.1038/nature18952 · Cited by 515
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Abbink, P., Larocca, R. A., Barrera, R. A. D. L., Bricault, C. A., Moseley, E. T., Boyd, M. B., Kirilova, M., Li, Z., Ng’ang’a, D., Nanayakkara, O., et al. (2016) · Science · doi:10.1126/science.aah6157 · Cited by 507
Risks associated with viral infections during pregnancy
Racicot, K. E., & Mor, G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87490 · Cited by 323
Zika viral dynamics and shedding in rhesus and cynomolgus macaques
Osuna, C. E., Lim, S., Deléage, C., Griffin, B. D., Stein, D. R., Schroeder, L. T., Omange, R. W., Best, K., Luo, M., Hraber, P., et al. (2016) · Nature Medicine · doi:10.1038/nm.4206 · Cited by 303
Onorati, M., Li, Z., Liu, F., Sousa, A. M. M., Nakagawa, N., Li, M., Dell’Anno, M. T., Gulden, F. O., Pochareddy, S., Tebbenkamp, A. T. N., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.038 · Cited by 292
The FDA-approved drug sofosbuvir inhibits Zika virus infection
Bullard, K. M., Govero, J., Zhu, Z., Salazar, V., Veselinović, M., Diamond, M., & Geiss, B. J. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.023 · Cited by 248
Synthetic and medicinal perspective of quinolines as antiviral agents
Kaur, R., & Kumar, K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113220 · Cited by 238
Swanstrom, J., Plante, J. A., Plante, K. S., Young, E., McGowan, E., Gallichotte, E. N., Widman, D. G., Heise, M. T., de Silva, A. M., & Baric, R. S. (2016) · mBio · doi:10.1128/mbio.01123-16 · Cited by 237
Neurologic Complications Associated With the Zika Virus in Brazilian Adults
da Silva, I. R. F., Frontera, J. A., de Filippis, A. M. B., & Nascimento, O. J. M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1703 · Cited by 232
Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review
Ahmed, M. U., Hanif, M., Ali, M. J., Haider, M. A., Kherani, D., Memon, G. M., Karim, A. H., & Sattar, A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00518 · Cited by 218
Modjarrad, K., Lin, L., George, S. L., Stephenson, K. E., Eckels, K. H., Barrera, R. A. D. L., Jarman, R. G., Sondergaard, E. L., Tennant, J., Ansel, J. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)33106-9 · Cited by 208
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
Dowd, K. A., DeMaso, C. R., Pelc, R. S., Speer, S. D., Smith, A. R. Y., Goo, L., Platt, D. J., Mascola, J. R., Graham, B. S., Mulligan, M. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.049 · Cited by 206
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys
Aïd, M., Abbink, P., Larocca, R. A., Boyd, M. B., Nityanandam, R., Nanayakkara, O., Martinot, A. J., Moseley, E. T., Blass, E., Borducchi, E. N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.008 · Cited by 205
Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology
Hirsch, A. J., Roberts, V. H. J., Grigsby, P. L., Haese, N. N., Schabel, M. C., Wang, X., Lo, J. O.-T., Liu, Z., Kroenke, C. D., Smith, J. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02499-9 · Cited by 200
Chan, J. F., Yip, C. C., Tsang, J. O., Tee, K., Cai, J., Chik, K. K., Zhu, Z., Chan, C. C., Choi, G. K.-Y., Sridhar, S., et al. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.99 · Cited by 188
An overview of mosquito vectors of Zika virus
Boyer, S., Calvez, E., Chouin-Carneiro, T., Diallo, D., & Failloux, A. (2018) · Microbes and Infection · doi:10.1016/j.micinf.2018.01.006 · Cited by 184
A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses
Yu, Y., Deng, Y., Zou, P., Wang, Q., Dai, Y., Yu, F., Du, L., Zhang, N., Tian, M., Hao, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15672 · Cited by 153
Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports
Rahimi, K. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04693-y · Cited by 149
Mustafá, Y. M., Meuren, L. M., Coelho, S. V. A., & de Arruda, L. B. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00525 · Cited by 141
Mapping the spatial distribution of Aedes aegypti and Aedes albopictus
Ding, F., Fu, J., Jiang, D., Hao, M., & Lin, G. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2017.11.020 · Cited by 130
Zika virus infection: an update
Ferraris, P., Yssel, H., & Missé, D. (2019) · Microbes and Infection · doi:10.1016/j.micinf.2019.04.005 · Cited by 126
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
Abbink, P., Larocca, R. A., Visitsunthorn, K., Boyd, M. B., Barrera, R. A. D. L., Gromowski, G. D., Kirilova, M., Peterson, R., Li, Z., Nanayakkara, O., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao4163 · Cited by 123
Flavivirus internalization is regulated by a size-dependent endocytic pathway
Hackett, B. A., & Cherry, S. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720032115 · Cited by 122
The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier
Chiu, C.-F., Chu, L.-W., Liao, I.-C., Simanjuntak, Y., Lin, Y., Juan, C., & Ping, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00214 · Cited by 118
Xavier‐Neto, J., Carvalho, M. D. O., Pascoalino, B. S., Cardoso, A. C., Costa, Â. M. S., Pereira, A. H. M., Santos, L. N., Saito, Â., Marques, R. E., Smetana, J. H. C., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005363 · Cited by 111
Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and Venezuela
Yépez, J. B., Murati, F. A., Petitto, M., Peñaranda, C. F., de Yepez, J. C., Maestre, G. E., & Arévalo, J. F. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0561 · Cited by 110
He, M., Zhang, H., Li, Y., Wang, G., Tang, B., Zhao, J., Huang, Y., & Zheng, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00722 · Cited by 108
Espíndola, O. D. M., Brandão, C. O., Gomes, Y. C. P., Siqueira, M. M., Soares, C., Lima, M. A., Leite, A. C. C. B., Torezani, G. S., Araújo, A., & Silva, M. T. T. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.044 · Cited by 108
Uncini, A., Shahrizaila, N., & Kuwabara, S. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314310 · Cited by 107
Calvert, A. E., Biggerstaff, B. J., Tanner, N. A., Lauterbach, M., & Lanciotti, R. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185340 · Cited by 106
Leonhard, S. E., Bresani-Salvi, C. C., Batista, J. D. L., da Cunha, S. S., Jacobs, B. C., Ferreira, M. L. B., & de Albuquerque, M. D. F. P. M. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008264 · Cited by 106
Masmejan, S., Musso, D., Vouga, M., Pomar, L., Dashraath, P., Stojanov, M., Panchaud, A., & Baud, D. (2020) · Pathogens · doi:10.3390/pathogens9110898 · Cited by 106
Zika virus infection: epidemiology, clinical manifestations and diagnosis
Calvet, G. A., dos Santos, F. B., & de Sequeira, P. C. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000301 · Cited by 105
Self-citationLin, E., Lantos, J. E., Strauß, S., Phillips, C. D., Campion, T. R., Navi, B. B., Parikh, N. S., Merkler, A. E., Mir, S. A., Zhang, C., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6793 · Cited by 105
Protective efficacy of Zika vaccine in AG129 mouse model
Sumathy, K., Kulkarni, B., Gondu, R. K., Ponnuru, S. K., Bonguram, N., Eligeti, R., Gadiyaram, S., Praturi, U., Chougule, B., Karunakaran, L., et al. (2017) · Scientific Reports · doi:10.1038/srep46375 · Cited by 104
Neurological Implications of Zika Virus Infection in Adults
Munoz-Arcos, L. S., Parra, B., Pardo, C. A., & Study, N. E. I. T. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix511 · Cited by 104
CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection
Hassert, M., Wolf, K. J., Schwetye, K. E., DiPaolo, R. J., Brien, J. D., & Pinto, A. K. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007237 · Cited by 103
Auteri, M., Russa, F. L., Blanda, V., & Torina, A. (2018) · BioMed Research International · doi:10.1155/2018/3098575 · Cited by 94
Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations
Guadarrama-Ortíz, P., Choreño-Parra, J. A., Sánchez-Martínez, C. M., Pacheco-Sánchez, F. J., Rodríguez-Nava, A. I., & García-Quintero, G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01039 · Cited by 92
Tatuene, J. K., Makepeace, B. L., Benjamin, L. A., Baylis, M., & Solomon, T. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000342 · Cited by 91
Self-citationZika vaccines and therapeutics: landscape analysis and challenges ahead
Wilder‐Smith, A., Vannice, K., Durbin, A. P., Hombach, J., Thomas, S. J., Thevarjan, I., & Simmons, C. P. (2018) · BMC Medicine · doi:10.1186/s12916-018-1067-x · Cited by 91
Fonseca, V., Libin, P., Theys, K., Faria, N. R., Nunes, M. R. T., Restovic, M. I., Freire, M., Giovanetti, M., Cuypers, L., Nowé, A., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007231 · Cited by 91
Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication
Webb, S., Wallace, V. C. J., Martín-López, D., & Yogarajah, M. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236182 · Cited by 90
Costa, V. V., Sarto, J. L. D., Rocha, R. D. P. F., da Silva, F. R., Doria, J. G., Olmo, I. G., Marques, R. E., Queiroz‐Junior, C. M., Foureaux, G., Araújo, J. M. S., et al. (2017) · mBio · doi:10.1128/mbio.00350-17 · Cited by 89
Prospects for a Zika Virus Vaccine
Barouch, D. H., Thomas, S. J., & Michael, N. L. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.005 · Cited by 88
Culex mosquitoes are experimentally unable to transmit Zika virus
Amraoui, F., Atyame, C. M., Vega-Rúa, A., Lourenço‐de‐Oliveira, R., Vazeille, M., & Failloux, A. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.35.30333 · Cited by 85
Schrauf, S., Tschismarov, R., Tauber, E., & Ramsauer, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00592 · Cited by 84
Rao, L., Wang, W., Meng, Q., Tian, M., Cai, B., Wang, Y., Li, A., Zan, M., Xiao, F., Bu, L., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03913 · Cited by 83
Axonal variants of Guillain–Barré syndrome: an update
Shang, P., Zhu, M., Wang, Y., Zheng, X., Wu, X., Zhu, J., Feng, J., & Zhang, H. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09742-2 · Cited by 79
A VSV-based Zika virus vaccine protects mice from lethal challenge
Emanuel, J., Callison, J. A., Dowd, K. A., Pierson, T. C., Feldmann, H., & Marzi, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29401-x · Cited by 76
Travel-Associated Zika Virus Disease Acquired in the Americas Through February 2016
Hamer, D. H., Barbre, K. A., Chen, L. H., Grobusch, M. P., Schlagenhauf, P., Goorhuis, A., van Genderen, P. J. J., Molina, I., Ásgeirsson, H., Kozarsky, P. E., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1842 · Cited by 75
Guillain–Barré syndrome and Zika virus outbreaks
Nascimento, O. J. M., & da Silva, I. R. F. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000471 · Cited by 74
A Reverse Genetics Platform That Spans the Zika Virus Family Tree
Widman, D. G., Young, E., Yount, B. L., Plante, K. S., Gallichotte, E. N., Carbaugh, D. L., Peck, K. M., Plante, J. A., Swanstrom, J., Heise, M. T., et al. (2017) · mBio · doi:10.1128/mbio.02014-16 · Cited by 73
Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
Bailey, M. J., Broecker, F., Duehr, J. E., Arumemi, F., Krammer, F., Palese, P., & Tan, G. S. (2019) · mBio · doi:10.1128/mbio.02861-18 · Cited by 73
Delineating antibody recognition against Zika virus during natural infection
Yu, L., Wang, R., Gao, F., Li, M., Liu, J., Wang, J., Hong, W., Zhao, L., Wen, Y., Yin, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93042 · Cited by 73
Xu, H., Hassounah, S. A., Colby-Germinario, S. P., Oliveira, M., Fogarty, C., Quan, Y., Han, Y.-S., Golubkov, O., Ibanescu, I., BRENNER, B. G., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw514 · Cited by 72
Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase
Hercík, K., Kozák, J., Šála, M., Dejmek, M., Hřebabecký, H., Zbornı́ková, E., Smola, M., Růžek, D., Nencka, R., & Bouřa, E. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.020 · Cited by 70
Zika virus infection reprograms global transcription of host cells to allow sustained infection
Tiwari, S. K., Dang, J. W., Qin, Y., Lichinchi, G., Bansal, V., & Rana, T. M. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.9 · Cited by 70
Arias, A., Torres-Tobar, L. A., Hernández, G., Paipilla, D., Palacios, E., Torres, Y., Duran, J., Ubiergo, S. U., Ardila-Sierra, A., & Castellanos, G. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.08.016 · Cited by 69
Mechanisms of Zika Virus Infection and Neuropathogenesis
Olagnier, D. P., Muscolini, M., Coyne, C. B., Diamond, M., & Hiscott, J. B. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3404 · Cited by 60
Development of standard methods for Zika virus propagation, titration, and purification
Coelho, S. V. A., Neris, R. L. S., Papa, M. P., Schnellrath, L. C., Meuren, L. M., Tschoeke, D. A., Leomil, L., Verçoza, B. R. F., Miranda, M. D., Thompson, F. L., et al. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.04.011 · Cited by 58
Dang, J. W., Tiwari, S. K., Qin, Y., & Rana, T. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.059 · Cited by 57
Vicenti, I., Boccuto, A., Giannini, A., Dragoni, F., Saladini, F., & Zazzi, M. (2017) · Virus Research · doi:10.1016/j.virusres.2017.11.003 · Cited by 56
Garcia, G., Paul, S., Beshara, S., Ramanujan, V. K., Ramaiah, A., Nielsen‐Saines, K., Li, M. M. H., French, S. W., Morizono, K., Kumar, A., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.12.005 · Cited by 56
Tai, W., He, L., Wang, Y., Sun, S., Zhao, G., Luo, C., Li, P. S., Zhao, H., Fremont, D. H., Li, F., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-017-0007-8 · Cited by 55
O’Connor, M. A., Tisoncik-Go, J., Lewis, T. B., Miller, C. J., Bratt, D., Moats, C. R., Edlefsen, P. T., Smedley, J. V., Klatt, N. R., Gale, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05826-w · Cited by 52
Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity
Chen, Y., Li, Y., Wang, X., & Zou, P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03079 · Cited by 52
Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
Halstead, S. B. (2017) · Emerging infectious diseases · doi:10.3201/eid2304.161879 · Cited by 51
Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2
Helbok, R., Beer, R., Löscher, W. N., Boesch, S., Reindl, M., Hornung, R., Schiefecker, A. J., Deisenhammer, F., & Pfausler, B. (2020) · European Journal of Neurology · doi:10.1111/ene.14388 · Cited by 50
Caragata, E. P., Rocha, M. N., Pereira, T. N., Mansur, S. B., Dutra, H. L. C., & Moreira, L. A. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007443 · Cited by 49
Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review
Possas, C. D. A., Brasil, P., Marzochi, M. C., Tanuri, A., Martins, R. D. M., Marques, E. T. A., Bonaldo, M. C., Ferreira, A. G., Lourenço‐de‐Oliveira, R., Nogueira, R. M. R., et al. (2017) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160510 · Cited by 48
Self-citationZika Virus Vaccine Development
Morabito, K. M., & Graham, B. S. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix464 · Cited by 48
Soto-Acosta, R., Xie, X., Shan, C., Baker, C. K., Shi, P., Rossi, S. L., García-Blanco, M. A., & Bradrick, S. S. (2018) · eLife · doi:10.7554/elife.39023 · Cited by 48
Lima, M. E. D. S., Bachur, T. P. R., & Aragão, G. F. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.105064 · Cited by 48
Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro
Балтина, Л. А., Lai, H., Liu, Y.-C., Huang, S.-H., Hour, M., Baltina, L. A., Nugumanov, T. R., Borisevich, S. S., Khalilov, L. M., Petrova, S. F., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116204 · Cited by 47
Neurologic Manifestation of Chikungunya Virus
Brizzi, K. T. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0561-1 · Cited by 46
Ricciardi, M. J., Magnani, D. M., Grifoni, A., Kwon, Y., Gutman, M. J., Grubaugh, N. D., Gangavarapu, K., Sharkey, M. E., Silveira, C. G. T., Bailey, V. K., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006000 · Cited by 46
Branche, E., Wang, Y.-T., Viramontes, K. M., Cuevas, J. M. V., Xie, J., Ana‐Sosa‐Batiz, F., Shafee, N., Duttke, S. H. C., McMillan, R. E., Clark, A. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33041-1 · Cited by 46
Willard, K. A., Demakovsky, L. R., Tesla, B., Goodfellow, F. T., Stice, S. L., Murdock, C. C., & Brindley, M. A. (2017) · Viruses · doi:10.3390/v9120383 · Cited by 44
Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys
Abbink, P., Larocca, R. A., Dejnirattisai, W., Peterson, R., Nkolola, J. P., Borducchi, E. N., Supasa, P., Mongkolsapaya, J., Screaton, G. R., & Barouch, D. H. (2018) · Nature Medicine · doi:10.1038/s41591-018-0056-0 · Cited by 44
Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24
Mazar, J., Li, Y., Rosado, A., Phelan, P. E., Kedarinath, K., Parks, G. D., Alexander, K. A., & Westmoreland, T. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200358 · Cited by 44
Guillain–Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series
Abolmaali, M., Heidari, M., Zeinali, M., Moghaddam, P., Ghamsari, M. R., Makiani, M. J., & Mirzaasgari, Z. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.11.013 · Cited by 43
Zika virus infection and microcephaly: Evidence regarding geospatial associations
Vissoci, J. R. N., Rocha, T. A. H., da Silva, N. C., Queiroz, R. C. D. S., Thomaz, É. B. A. F., Amaral, P., Lein, A. C., Branco, M. D. R. F. C., Aquino, J., Rodrigues, Z. M. R., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006392 · Cited by 43
Maciejewski, S. M., Ruckwardt, T. J., Morabito, K. M., Foreman, B. M., Burgomaster, K. E., Gordon, D. N., Pelc, R. S., DeMaso, C. R., Ko, S., Fisher, B. E., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw9066 · Cited by 43
Miller Fisher syndrome and COVID-19: is there a link?
Ray, A. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236419 · Cited by 42
de Carvalho, O. V., Félix, D. M., de Mendonça, L. R., de Araújo, C. M. C. S., França, R. F. D. O., Cordeiro, M. T., Júnior, A. S., & Pena, L. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.08.016 · Cited by 41
T Cell Immunity and Zika Virus Vaccine Development
Lima, N. S., Rolland, M., Modjarrad, K., & Trautmann, L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.05.004 · Cited by 40
Kato, F., Tajima, S., Nakayama, E., Kawai, Y., Taniguchi, S., Shibasaki, K.-I., Taira, M., Maeki, T., Lim, C., Takasaki, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16475-2 · Cited by 40
Design, synthesis and discovery of andrographolide derivatives against Zika virus infection
Li, F., Lee, E. M., Sun, X., Wang, D., Tang, H., & Zhou, G. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111925 · Cited by 40
Cellular Organelles Reorganization During Zika Virus Infection of Human Cells
García, C. C., Vázquez, C., Giovannoni, F., Russo, C., Cordo, S. M., Alaimo, A., & Damonte, E. B. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01558 · Cited by 40
Hamer, D. H., Wilson, M. E., Jean, J., & Chen, L. H. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0571-z · Cited by 39
Identification of a pocket factor that is critical to Zika virus assembly
DiNunno, N. M., Goetschius, D. J., Narayanan, A., Majowicz, S. A., Moustafa, I. M., Bator, C. M., Hafenstein, S. L., & Jose, J. (2020) · Nature Communications · doi:10.1038/s41467-020-18747-4 · Cited by 39
Impact of Zika Virus Emergence in French Guiana: A Large General Population Seroprevalence Survey
Flamand, C., Bailly, S., Fritzell, C., Berthelot, L., Vanhomwegen, J., Salje, H., Paireau, J., Matheus, S., Enfissi, A., Fernandes‐Pellerin, S., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz396 · Cited by 38
Zika clinical updates: implications for pediatrics
Adachi, K., & Nielsen‐Saines, K. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000582 · Cited by 36
Dong, S., Kang, S., & Dimopoulos, G. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007681 · Cited by 36
Zika Virus Overview: Transmission, Origin, Pathogenesis, Animal Model and Diagnosis
Vue, D., & Tang, Q. (2021) · Zoonoses · doi:10.15212/zoonoses-2021-0017 · Cited by 36
ICR suckling mouse model of Zika virus infection for disease modeling and drug validation
Wu, Y.-H., Tseng, C.-K., Lin, C.-K., Wei, C.-K., Lee, J.-C., & Young, K.-C. (2018) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006848 · Cited by 35
Acetylation of the NS3 helicase by KAT5γ is essential for flavivirus replication
Serman, T. M., Chiang, C., Liu, G., Sayyad, Z., Pandey, S., Volčič, M., Lee, H., Muppala, S., Acharya, D., Goins, C. M., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.06.013 · Cited by 35
Metadata
- Authors
- Brasil, P., Sequeira, P. C., Freitas, A. D., Zogbi, H. E., Calvet, G. A., de Souza, R. V., Siqueira, A. M., de Mendonca, M. C. L., Nogueira, R. M. R., de Filippis, A. M. B., & Solomon, T.
- Affiliations
- Instituto Nacional de Infectologia Evandro Chagas (BR)
- Instituto Oswaldo Cruz (BR)
- University of Liverpool (GB)
- Corresponding author
- Brasil, Patrícia
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 387
- Issue
- 10026
- Pages
- 1482
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2335029448
- Cited by
- 299
- References
- 6
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 22 · 2023: 12 · 2022: 17 · 2021: 29 · 2020: 37 · 2019: 46 · 2018: 36 · 2017: 54 · 2016: 37
- FWCI
- 57.19
- Type
- journal article
- Language
- en
- Open access
- green
- arca.fiocruz.br
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- Funders
- National Institute for Health Research Health Protection Research Unit
- National Institute for Health and Care Research (IS-HPU-1112−10117, RP-PG-0108-10048, NF-SI-0514-10177)
- National Institutes of Health
- Medical Research Council (MC_PC_15096)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- Guillain-Barré syndrome, Zika virus infection, paresthesia, rash, mosquito-borne diseases
- MeSH terms
- Zika Virus Infection, Zika Virus, Brazil, DNA, Viral, Female, Humans, Guillain-Barre Syndrome, Young Adult, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review